All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Evaluation of Accommodation and Pupillary Reaction in Children with Myopia Treated by Highly Diluted Atropine in the M.A.R.S Trial

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F24%3A00137853" target="_blank" >RIV/00216224:14110/24:00137853 - isvavai.cz</a>

  • Result on the web

    <a href="https://www.onlinescientificresearch.com/articles/evaluation-of-accommodation-and-pupillary-reaction-in-children-with-myopia-treated-by-highly-diluted-atropine-in-the-mars-trial.pdf" target="_blank" >https://www.onlinescientificresearch.com/articles/evaluation-of-accommodation-and-pupillary-reaction-in-children-with-myopia-treated-by-highly-diluted-atropine-in-the-mars-trial.pdf</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.47363/JCCSR/2024(6)327" target="_blank" >10.47363/JCCSR/2024(6)327</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Evaluation of Accommodation and Pupillary Reaction in Children with Myopia Treated by Highly Diluted Atropine in the M.A.R.S Trial

  • Original language description

    Background: Myopia is a growing challenge in paediatric ophthalmology. Despite the benefits of novel therapeutic approaches, it is essential to assess their side effects. The aim of this study was to determine the impact of twelve months of local application of 0.02% and 0.04% atropine and placebo on the static and dynamic features of accommodation and pupil diameter, representing prominent side effects of myopia progression treatment. Methods: This study involved 127 subjects aged 6-11 years who were randomized to the M.A.R.S. trial, a randomized, double-masked, placebo-controlled multicentre study investigating the efficacy, safety, and side effects of highly diluted atropine collyrium (0.02% and 0.04%) in slowing the progression of myopia. Photopic and mesopic light-adapted horizontal pupillary diameters (PD; mm) were measured. Static accommodation capability was assessed monocularly and binocularly as the amplitude of accommodation (AoA; dioptres) calculated as the inverted value of the measured near point of accommodation in meters. The dynamic properties of accommodation were represented by the near accommodation facility (NAF, ±1.25 D flipper; monocularly/binocularly; number of cycles in a 60-second interval). Results: The effects of atropine on static PD were treatment-related (P&lt;0.001) and dose-unrelated. Under photopic and mesopic light conditions, changes from baseline after twelve months of treatment were observed: in the 0.02% atropine group: from 3.48 ±1.23 to 4.65 ±1.52 (P&lt;0.001); from 5.59 ±1.34 to 6.33 ±1.14 (P&lt;0.001), respectively; in the 0.04% group: from 3.41±1.27 to 4.86±1.64 (P&lt;0.001); and from 5.64±1.13 to 6.55±0.82 (P&lt;0.001), respectively. The effects of the study medication on AoA were not treatment-related in the break point and were marginally treatment-related in the recovery point (P=0.049) in monocular tests. The results of the binocular tests were treatment-unrelated in the break point or at the recovery point. There were no statistically significant differences in NAF among the groups after the 12-month treatment period in monocular and binocular conditions. Conclusions: Local 0.02% and 0.04% atropine treatment for twelve months resulted in treatment-related increases in photopic and mesopic PD, respectively. Accommodation capability, assessed by AoA, was diminished by atropine treatment only at extreme limits (due to enlarged NPA distances) but remained unchanged at standard near working distances (as indicated by unaltered NAF test results) according to the M.A.R.S. trial data.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>ost</sub> - Miscellaneous article in a specialist periodical

  • CEP classification

  • OECD FORD branch

    30207 - Ophthalmology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2024

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Clinical Case Studies Reviews & Reports

  • ISSN

    2634-680X

  • e-ISSN

  • Volume of the periodical

    6

  • Issue of the periodical within the volume

    9

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    9

  • Pages from-to

    1-9

  • UT code for WoS article

  • EID of the result in the Scopus database